Transparency

Angelini Pharma UK-I (part of Angelini Pharma Group) is a modern organisation with Compliance and Transparency imbedded in its core corporate values.
Angelini Pharma UK-I is accountable for compliance with local laws, regulations and industry codes including the Association of the British Pharmaceutical Industry (ABPI) Code of Practice and the Irish Pharmaceutical Healthcare Association (IPHA) Code of Practice.
Angelini Pharma UK-I is committed to ensuring that Transparency is respected by annually disclosing Transfers of Value to Health Professionals, Other Relevant Decision Makers and Healthcare Organisations. For more information and recent disclosures in the UK, see https://www.abpi.org.uk/reputation/disclosure-uk and for information and recent disclosures in the Republic of Ireland, see https://www.transferofvalue.ie/.
Angelini Pharma UK-I is annually disclosing Contracted Services, Donations, Grants and Sponsorship (including in relation to events/meetings) Provided to Patient Organisations and Contracted Services Provided by the Public, Including Patients and Journalists below.
ABPI Disclosures (Patient Organisations and Members of the Public)
IPHA Disclosures
2021 Disclosure of payments (HCPs, HCOs and R&D)
2024 Disclosure of payments (Patient Organisations)
Methodological Note (ABPI and IPHA)
Angelini Pharma UKI Methodology
Job code: MAT-UKI-0245-NP Date: June 2025